Inventor · disambiguated record
Jay Thomas Backstrom
Also filed as: BACKSTROM JAY · BACKSTROM JAY T · BACKSTROM JAY THOMAS
6 granted patents·11 pending applications·29 citations·filing 2008–2024
82Inventor score
Top patents by PatentIndex Score
17 records- 0192US10646503B2Isotopologues of 5-azacytidineCELGENE CORP·Filed 2019·Granted May 12, 2020·2 cites·1 claims
- 0291US11571436B2Oral formulations of cytidine analogs and methods of use thereofCELGENE CORP·Filed 2021·Granted Feb 7, 2023·1 cites·22 claims
- 0391US8846628B2Oral formulations of cytidine analogs and methods of use thereofETTER JEFFREY B·Filed 2009·Granted Sep 30, 2014·20 cites·43 claims
- 0490US2025082661A1Oral formulations of cytidine analogs and methods of use thereofCELGENE CORP·Filed 2024·Application pending·0 cites
- 0588US10463683B2Isotopologues of 5-azacytidineCELGENE CORP·Filed 2019·Granted Nov 5, 2019·3 cites·1 claims
- 0687US12053482B2Oral formulations of cytidine analogs and methods of use thereofCELGENE CORP·Filed 2023·Granted Aug 6, 2024·0 cites·21 claims
- 0787US10220050B2Isotopologues of 5-azacytidineCELGENE CORP·Filed 2017·Granted Mar 5, 2019·3 cites·1 claims
- 0884US2023241086A1Oral formulations of cytidine analogs and methods of use thereofCELGENE CORP·Filed 2022·Application pending·0 cites
- 0980US2022105118A1Oral formulations of cytidine analogs and methods of use thereofCELGENE CORP·Filed 2021·Application pending·0 cites
- 1072US2020316099A1Isotopologues of 5-azacytidineCELGENE CORP·Filed 2020·Application pending·0 cites
- 1168US2015056280A1Isotopologues of 5-azacytidineCELGENE CORP·Filed 2014·Application pending·0 cites
- 1260US2015374732A1Oral formulations of cytidine analogs and methods of use thereofCELGENE CORP·Filed 2015·Application pending·0 cites
- 1352US2016250246A1Oral formulations of cytidine analogs and methods of use thereofCELGENE CORP·Filed 2016·Application pending·0 cites
- 1450US2015290228A1Oral formulations of cytidine analogs and methods of use thereofBACKSTROM JAY T·Filed 2015·Application pending·0 cites
- 1545US2023181690A1Methods for treating anemia using an actriib ligand trap and fedratinibCELGENE CORP·Filed 2021·Application pending·0 cites
- 1638US2018125928A1Treatment of beta-thalassemia using actrii ligand trapsCELGENE CORP·Filed 2016·Application pending·0 cites
- 1736US2010311683A1Cytidine analogs for treatment of myelodysplastic syndromesBEACH C L·Filed 2008·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Jay Thomas Backstrom files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →